Translational Windows in Chordoma: A Target Appraisal
Chordomas are rare tumors that are notoriously refractory to chemotherapy and radiotherapy when radical surgical resection is not achieved or upon recurrence after maximally aggressive treatment. The study of chordomas has been complicated by small patient cohorts and few available model systems due...
Main Authors: | Samantha E. Hoffman, Sally A. Al Abdulmohsen, Saksham Gupta, Blake M. Hauser, David M. Meredith, Ian F. Dunn, Wenya Linda Bi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2020.00657/full |
Similar Items
-
Chordomas, malignant spinal tumors
by: Niki Adrian Calina, et al.
Published: (2016-03-01) -
Poorly differentiated chordoma
by: Li Yang, et al.
Published: (2022-06-01) -
Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining
by: Bharat Rekhi, et al.
Published: (2017-01-01) -
Selinexor inhibits growth of patient derived chordomas in vivo as a single agent and in combination with abemaciclib through diverse mechanisms
by: Christopher J. Walker, et al.
Published: (2022-08-01) -
Immunotherapy as a Promising Option for the Treatment of Advanced Chordoma: A Systemic Review
by: Xiang Wang, et al.
Published: (2022-12-01)